新型冠状病毒病2019重症患者的谵妄发生率、持续时间与严重程度
结果显示无昏迷的谵妄发生率为29.1%,首次CAM-ICU评估阳性率61.9%,低活动型谵妄最常见(87.4%),至第14天中位无谵妄/昏迷天数为5天,中位CAM-ICU-7评分为6.5分提示重度谵妄。机械通气与谵妄发生风险独立相关(OR 5.0,95%CI 1.1-22.2,P=0.033),即使校正镇静药物后仍显著。研究提示需临床关注COVID-19 ICU患者谵妄的持续时间与严重程度。
要点
- COVID-19 ICU患者中29.1%发生无昏迷的谵妄,首次CAM-ICU评估阳性率高达61.9%,低活动型占87.4%。
- 至第14天中位无谵妄/昏迷天数仅5天(IQR 4-11天),中位CAM-ICU-7评分6.5分(IQR 5-7),提示谵妄严重。
- 机械通气与谵妄发生风险独立相关(OR 5.0,95%CI 1.1-22.2,P=0.033),校正镇静药物后仍显著。
- 队列中78.4%患者被开具苯二氮䓬类药物,但原文未提供剂量或用法信息。
- 研究未发现组间死亡率差异(原文未提供具体数值)。
适用人群与场景
- 2020年3月1日至6月7日连续收入两个学术中心ICU、鼻咽拭子SARS-CoV-2 PCR阳性的成人患者。
- 排除年龄<18岁、无任何谵妄评估或无出院去向的患者。
- 场景为ICU,评估谵妄结局至入ICU后前14天。
诊断标准与关键阈值
- 谵妄评估工具为CAM-ICU(Confusion Assessment Method for the ICU),首次评估阳性即判定谵妄。
- 谵妄严重程度用CAM-ICU-7评分评估,中位评分6.5分(IQR 5-7)提示严重谵妄。
- 谵妄亚型中低活动型最常见(87.4%)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 无昏迷的谵妄发生率为29.1%,昏迷前谵妄为27.9%,昏迷后谵妄为23.1%;首次CAM-ICU评估阳性率61.9%。
- 低活动型谵妄为最常见亚型(87.4%);至第14天中位无谵妄/昏迷天数为5天(IQR 4-11天),中位CAM-ICU-7评分6.5分(IQR 5-7)。
- 78.4%患者被开具苯二氮䓬类药物;机械通气与谵妄发生风险独立相关(OR 5.0,95%CI 1.1-22.2,P=0.033),校正镇静药物后仍显著。
- 组间死亡率无差异(原文未提供具体数值)。
证据类型、等级与局限
- 证据类型:回顾性数据提取研究(队列设计)。
对床旁实践的改变
- 对COVID-19 ICU患者应常规使用CAM-ICU筛查谵妄,尤其注意低活动型谵妄(占87.4%)易被漏诊。
- 机械通气患者谵妄风险更高(OR 5.0),即使校正镇静药物后仍显著,提示需加强此类患者的谵妄监测与干预。
- 原文未提供具体谵妄预防或治疗药物方案,不能据此改变镇静药物选择或剂量。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine delirium occurrence rate, duration, and severity in patients admitted to the ICU with coronavirus disease 2019.
DESIGN: Retrospective data extraction study from March 1, 2020, to June 7, 2020. Delirium outcomes were assessed for up to the first 14 days in ICU.
SETTING: Two large, academic centers serving the state of Indiana.
PATIENTS: Consecutive patients admitted to the ICU with positive severe acute respiratory syndrome coronavirus 2 nasopharyngeal swab polymerase chain reaction test from March 1, 2020, to June 7, 2020, were included. Individuals younger than 18 years of age, without any delirium assessments, or without discharge disposition were excluded.
MEASUREMENTS AND MAIN RESULTS: Primary outcomes were delirium rates and duration, and the secondary outcome was delirium severity. Two-hundred sixty-eight consecutive patients were included in the analysis with a mean age of 58.4 years (sd, 15.6 yr), 40.3% were female, 44.4% African American, 20.7% Hispanic, and a median Acute Physiology and Chronic Health Evaluation II score of 18 (interquartile range, 13-25). Delirium without coma occurred in 29.1% of patients, delirium prior to coma in 27.9%, and delirium after coma in 23.1%. The first Confusion Assessment Method for the ICU assessment was positive for delirium in 61.9%. Hypoactive delirium was the most common subtype (87.4%). By day 14, the median number of delirium/coma-free were 5 days (interquartile range, 4-11 d), and median Confusion Assessment Method for the ICU-7 score was 6.5 (interquartile range, 5-7) indicating severe delirium. Benzodiazepines were ordered for 78.4% of patients in the cohort. Mechanical ventilation was associated with greater odds of developing delirium (odds ratio, 5.0; 95% CI, 1.1-22.2; p = 0.033) even after adjusting for sedative medications. There were no between-group differences in mortality.
CONCLUSIONS: Delirium without coma occurred in 29.1% of patients admitted to the ICU. Delirium persisted for a median of 5 days and was severe. Mechanical ventilation was significantly associated with odds of delirium even after adjustment for sedatives. Clinical attention to manage delirium duration and severity, and deeper understanding of the virus' neurologic effects is needed for patients with coronavirus disease 2019.
参考来源
- Khan SH, Lindroth H, Perkins AJ, et al. Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Explor. 2020. PMID: 33251519. doi:10.1097/CCE.0000000000000290
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。